Blog | Dr. Rakesh Srivastava

October 31, 2021November 27, 2021Rakesh Srivastava PH.D

SATB2 is a Novel Biomarker and Therapeutic Target for Cancer – Rakesh Srivastava

A few examinations have affirmed the association of malignant growth undifferentiated organisms (CSC) in cancer movement, metastasis, drug opposition and disease backslide. […]

June 10, 2020November 27, 2021Rakesh Srivastava PH.D

Chemoprevention by Resveratrol : Molecular Mechanisms and Therapeutic Potential

Sharmila Shankar, Gyanendra Singh, Rakesh K. Srivastava Department of Biochemistry, University of Texas Health Science Center at Tyler, Tyler, Texas, USA 75703 TABLE […]

June 10, 2020November 27, 2021Rakesh Srivastava PH.D

Chronic Ethanol Exposure of Human Pancreatic Normal Ductal Epithelial Cells Induces Cancer Stem Cell Phenotype through SATB2

Wei YuYuming MaSharmila ShankarRakesh K. Srivastava Abstract The incidence of pancreatic cancer is on the rise. Risk factors for pancreatic cancer include […]

June 10, 2020November 27, 2021Rakesh Srivastava PH.D

Rakesh Srivastava Research Discovers Potential New Rx Target For Colon Cancer

SATB2 is a novel “transcription factor” – a protein “switch” that controls which genes are turned on or off inside a cancer cell. Drs. […]

June 10, 2020October 28, 2021Rakesh Srivastava PH.D

Volkin, Rakesh Srivastava Named KU’s Second, Third Eminent Scholars

Kansas Bioscience Authority Commits $4.3 Million To Support Professors A prominent pharmaceutical scientist with 20 years of industrial research and development experience […]